Aurora Spine Corporation (ASAPF)
- Previous Close
0.3230 - Open
0.3100 - Bid 0.2900 x --
- Ask 0.3399 x --
- Day's Range
0.3100 - 0.3100 - 52 Week Range
0.1616 - 0.3430 - Volume
2,500 - Avg. Volume
17,930 - Market Cap (intraday)
22.251M - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Oct 24, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L spinal fusion system. The company was founded in 2013 and is headquartered in Toronto, Canada.
www.aurora-spine.comRecent News: ASAPF
View MorePerformance Overview: ASAPF
Trailing total returns as of 10/28/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ASAPF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ASAPF
View MoreValuation Measures
Market Cap
26.02M
Enterprise Value
29.24M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.58
Price/Book (mrq)
5.34
Enterprise Value/Revenue
1.82
Enterprise Value/EBITDA
90.77
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.76%
Return on Assets (ttm)
-2.50%
Return on Equity (ttm)
-14.52%
Revenue (ttm)
16.9M
Net Income Avi to Common (ttm)
-635.51k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
882.05k
Total Debt/Equity (mrq)
73.68%
Levered Free Cash Flow (ttm)
-449.18k
Research Analysis: ASAPF
View MoreCompany Insights: ASAPF
ASAPF does not have Company Insights